BioCardia's CardiAMP Completes Japan Pre-Market Consultation, First Cardiac Cell Therapy to Do So
· techtimes.com · popularity 19/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at techtimes.com →
Summary
BioCardia's CardiAMP cleared Japan's PMDA consultation - a first for catheter-delivered cardiac cell therapy. Biomarker-screened patients showed 47% lower cardiac death.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 7.